ZEVRA THERAPEUTICS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 09/30/23 | FY 12/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $106.5 | $23.6 | $27.5 | — | $10.2 |
| Operating income | -$62.9 | -$87.0 | -$49.6 | — | -$42.6 |
| Net income | $83.2 | -$105.5 | -$46.0 | — | -$26.8 |
| Balance Sheet | |||||
| Total debt | $63.6 | $61.6 | — | — | — |
| Cash Flow Statement | |||||
| Free cash flow | -$2.4 | -$69.7 | -$33.8 | — | -$18.8 |
| Share repurchases | — | $0.0 | $3.4 | — | $4.7 |
Shares outstanding 59.4M · Free float 91.0%
Annual filing data through FY ended December 31, 2025; float as of September 10, 2026.